AMG-510
4-((S)-4-acryloyl-2-methylpiperazin-1-yl)-6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidin-2(1H)-one
2252403-56-6

4-((S)-4-acryloyl-2-methylpiperazin-1-yl)-6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidin-2(1H)-one; CAS 2252403-56-6 is a discovery compound showing potential in the treatment of patients with previously treated metastatic non–small cell lung cancer (NSCLC) harboring a KRAS G12C mutation

Fountainbridge’s network of suppliers allows us to supply a wide range of pharmaceutical intermediates on kg-Mt scale. We are able to supply the products below, please Contact Us for a quotation for these or any other products of interest.